Literature DB >> 22987394

Re-assigned diagnosis of D4ST1-deficient Ehlers-Danlos syndrome (adducted thumb-clubfoot syndrome) after initial diagnosis of Marden-Walker syndrome.

Kevin A Winters1, Zhijie Jiang, Weihong Xu, Shibo Li, Zineb Ammous, Parul Jayakar, Klaas J Wierenga.   

Abstract

We report on a 16-year-old female originally diagnosed with Marden-Walker syndrome due to features such as facial dysmorphism, several musculoskeletal anomalies, and atrial septal defect in addition to hypoplasia of the inferior vermis with normal-sized cerebellum and absence of the septum pellucidum. However, an SNP array performed at age 15 years detected a total of 142 Mb of long runs of homozygosity (ROH), and put the diagnosis in doubt. Using the Genomic Oligoarray and SNP array evaluation tool (http://www.ccs.miami.edu/ROH), CHST14 provided a "hit" as a gene mapping to the largest ROH region associated with a phenotype matching our patient's (if mutated). At that time, she was a cognitively intact, thin female with growth parameters below the 3rd percentile. Craniofacial features included microcephaly, midface hypoplasia, blepharophimosis, entropion, myopia, microretrognathia, and dental malocclusion. Musculoskeletal features included kyphoscoliosis, arachnodactyly, camptodactyly, and rocker-bottom feet with interphalangeal contractures. Her skin displayed large ecchymoses and poorly healed atrophic scars. Sequencing of CHST14 revealed a complex homozygous frameshift mutation involving a 7-bp deletion and an 11-bp insertion predicted to produce a truncated protein. This mutation was not seen in 100 controls of various ethnicities. Thus, our patient represents not only a novel (homozygous) mutation in CHST14, but is also the first patient with dermatan 4-O-sulfotransferase 1-deficient Ehlers-Danlos syndrome (adducted thumb-clubfoot syndrome) (DD-EDS ATCS) documented in the Western Hemisphere. Furthermore, our patient's central nervous system anomalies have not before been described in DD-EDS (ATCS).
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22987394     DOI: 10.1002/ajmg.a.35613

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  10 in total

1.  The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations.

Authors:  Andreas R Janecke; Ben Li; Manfred Boehm; Birgit Krabichler; Marianne Rohrbach; Thomas Müller; Irene Fuchs; Gretchen Golas; Yasuhiro Katagiri; Shira G Ziegler; William A Gahl; Yael Wilnai; Nicoletta Zoppi; Herbert M Geller; Cecilia Giunta; Anne Slavotinek; Beat Steinmann
Journal:  Am J Med Genet A       Date:  2015-09-16       Impact factor: 2.802

Review 2.  The Specific Role of Dermatan Sulfate as an Instructive Glycosaminoglycan in Tissue Development.

Authors:  Shuji Mizumoto; Shuhei Yamada
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

3.  Evidence of recessive Alzheimer disease loci in a Caribbean Hispanic data set: genome-wide survey of runs of homozygosity.

Authors:  Mahdi Ghani; Christine Sato; Joseph H Lee; Christiane Reitz; Danielle Moreno; Richard Mayeux; Peter St George-Hyslop; Ekaterina Rogaeva
Journal:  JAMA Neurol       Date:  2013-10       Impact factor: 18.302

4.  A clinical evaluation tool for SNP arrays, especially for autosomal recessive conditions in offspring of consanguineous parents.

Authors:  Klaas J Wierenga; Zhijie Jiang; Amy C Yang; John J Mulvihill; Nicholas F Tsinoremas
Journal:  Genet Med       Date:  2012-10-25       Impact factor: 8.822

Review 5.  Human genetic disorders and knockout mice deficient in glycosaminoglycan.

Authors:  Shuji Mizumoto; Shuhei Yamada; Kazuyuki Sugahara
Journal:  Biomed Res Int       Date:  2014-07-13       Impact factor: 3.411

Review 6.  Pathophysiological Significance of Dermatan Sulfate Proteoglycans Revealed by Human Genetic Disorders.

Authors:  Shuji Mizumoto; Tomoki Kosho; Shuhei Yamada; Kazuyuki Sugahara
Journal:  Pharmaceuticals (Basel)       Date:  2017-03-27

Review 7.  Recent Advances in the Pathophysiology of Musculocontractural Ehlers-Danlos Syndrome.

Authors:  Tomoki Kosho; Shuji Mizumoto; Takafumi Watanabe; Takahiro Yoshizawa; Noriko Miyake; Shuhei Yamada
Journal:  Genes (Basel)       Date:  2019-12-29       Impact factor: 4.096

8.  Clinical and molecular features of 66 patients with musculocontractural Ehlers-Danlos syndrome caused by pathogenic variants in CHST14 (mcEDS-CHST14).

Authors:  Mari Minatogawa; Ai Unzaki; Hiroko Morisaki; Delfien Syx; Tohru Sonoda; Andreas R Janecke; Anne Slavotinek; Nicol C Voermans; Yves Lacassie; Roberto Mendoza-Londono; Klaas J Wierenga; Parul Jayakar; William A Gahl; Cynthia J Tifft; Luis E Figuera; Yvonne Hilhorst-Hofstee; Alessandra Maugeri; Ken Ishikawa; Tomoko Kobayashi; Yoko Aoki; Toshihiro Ohura; Hiroshi Kawame; Michihiro Kono; Kosuke Mochida; Chiho Tokorodani; Kiyoshi Kikkawa; Takayuki Morisaki; Tetsuyuki Kobayashi; Takaya Nakane; Akiharu Kubo; Judith D Ranells; Ohsuke Migita; Glenda Sobey; Anupriya Kaur; Masumi Ishikawa; Tomomi Yamaguchi; Naomichi Matsumoto; Fransiska Malfait; Noriko Miyake; Tomoki Kosho
Journal:  J Med Genet       Date:  2021-11-23       Impact factor: 5.941

Review 9.  Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review.

Authors:  Sanne D'hondt; Tim Van Damme; Fransiska Malfait
Journal:  Genet Med       Date:  2017-10-05       Impact factor: 8.822

10.  Oral Conditions and Oral Health-Related Quality of Life of People with Ehlers-Danlos Syndromes (EDS): A Questionnaire-Based Cross-Sectional Study.

Authors:  Marcel Hanisch; Moritz Blanck-Lubarsch; Lauren Bohner; Dominik Suwelack; Johannes Kleinheinz; Jeanette Köppe
Journal:  Medicina (Kaunas)       Date:  2020-09-04       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.